Hemophilia Healthcare Market: Competitive Landscape and Development Trends
Few rare disease categories have seen as much commercial activity in recent years as hemophilia. New drug classes, expanding diagnosis efforts, and shifting reimbursement models are all converging at once, and the result is a hemophilia treatment market that looks meaningfully different than it did just five years ago. Starting With Geography: The US No…
